Intuitive Surgical Inc. ($ISRG) Stock Forecast: Down 5.5% Today

What is Intuitive Surgical Inc.?

Intuitive Surgical (ISRG) is a leading company in AI-driven robotic surgery, known for its da Vinci and Ion surgical systems. The company has reported strong revenue growth and procedure volumes in the past year.

Why is Intuitive Surgical Inc. going down?

ISRG stock is down 5.5% on Jan 14, 2026 15:51

• Despite strong Q4 revenue and procedure growth, ISRG's stock saw a 6% decline in pre-market trading.
• Concerns regarding a slowdown in Ion endoluminal system placements, despite an increase in da Vinci system placements, appear to have fueled the bearish movement.
• Investor sentiment may have been influenced by the company's anticipation of a potential deceleration in da Vinci procedures growth for 2026.
• Watching for the stock's current undervaluation in comparison to estimated fair value, as well as expected advancements in AI-enabled surgery, could be crucial for potential future market movements.

ISRG Price Chart

ISRG Technical Analysis

ISRG News

Intuitive stock falls despite strong Q4 procedure growth, revenue beat

Intuitive's stock dropped by 6% in pre-market trading despite reporting strong preliminary Q4 2025 revenue of $2.87 billion, surpassing analyst estimates, and an 18% increase in worldwide procedures. The decline appears to be driven by investor concerns over a slowdown in Ion endoluminal system placements, which decreased compared to the previous year, even as da Vinci system placements rose. The company projects a 13% to 15% growth in da Vinci procedures for 2026, a potential slowdown from 2025.

https://www.investing.com/news/stock-market-news/intuitive-stock-falls-despite-strong-q4-procedure-growth-revenue-beat-93CH-4447442

Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results

Intuitive (Nasdaq: ISRG) announced strong preliminary unaudited financial results for the fourth quarter and full year 2025, with revenue and procedure volumes increasing significantly. The company reported a 19% increase in worldwide procedures for the full year 2025 and a 21% increase in revenue to approximately $10.06 billion, driven by increased adoption of its da Vinci and Ion surgical systems. Intuitive expects worldwide da Vinci procedures to grow by 13% to 15% in 2026.

https://www.globenewswire.com/news-release/2026/01/14/3218745/7637/en/Intuitive-Announces-Preliminary-Fourth-Quarter-and-Full-Year-2025-Results.html

A Look At Intuitive Surgical (ISRG) Valuation As AI Surgery Expectations Build Ahead Of Earnings

Intuitive Surgical (ISRG) is currently trading at $561.82, which is 5.8% undervalued compared to an estimated fair value of $596.36, driven by expectations of AI-enabled diagnostics and software improving margins and procedure volumes. Despite strong long-term share price performance, its high P/E ratio of 72.5x introduces risk if growth or margins falter. Investors are keenly awaiting the January 22 earnings report for further insights into its AI-driven growth and recurring revenue potential.

https://simplywall.st/stocks/us/healthcare/nasdaq-isrg/intuitive-surgical/news/a-look-at-intuitive-surgical-isrg-valuation-as-ai-surgery-ex

Why Congress Is Buying Intuitive Surgical Ahead of Earnings

Intuitive Surgical (ISRG) is positioned for a potential rally before its October 21, 2025 earnings report, driven by new FDA approvals and European expansion, which have significantly enlarged its addressable market. The company, a leader in AI-driven robotic surgery, is benefiting from recent legislative buying activity and a discounted stock price relative to its 52-week high. Analysts foresee a substantial upside, especially as the broader healthcare sector is undervalued.

https://br.tradingview.com/news/marketbeat%3A9f234d8b5094b%3A0-why-congress-is-buying-intuitive-surgical-ahead-of-earnings/

AngioDynamics to lay off 54 workers in Glens Falls, Queensbury

AngioDynamics, a medical device manufacturing company, plans to lay off 54 workers in Glens Falls and Queensbury, New York, starting February 27, 2026. The layoffs are due to "contract loss" and affect nonunion employees across three sites. This follows a previous announcement in 2024 to close these sites to save $15 million, though the company later decided to retain most of its workforce in Warren County, citing strong performance.

https://www.timesunion.com/news/article/angoidynamics-to-lay-off-54-workers-21292841.php

Trending Today

Wingstop Inc. ($WING) Stock Forecast: Up 5.1% Today

Cassava Sciences, Inc. ($SAVA) Stock Forecast: Down 5.4% Today

Litecoin ($LTC) Crypto Forecast: Up 5.1% Today

Solana ($SOL) Crypto Forecast: Up 5.7% Today

Peabody Energy Corporation ($BTU) Stock Forecast: Down 5.0% Today

GameStop Corp. ($GME) Stock Forecast: Up 5.3% Today

Natural Gas ($GAS) Commodity Forecast: Up 7.3% Today

Cardano ($ADA) Crypto Forecast: Up 5.2% Today

Pepe ($PEPE) Crypto Forecast: Up 5.3% Today

Jack Henry & Associates Inc. ($JKHY) Stock Forecast: Down 3.3% Today

Intuitive Surgical Inc. Price History

23.03.2025 - ISRG Stock was up 7.0%

• Intuitive Surgical reported impressive Q1 earnings and revenue, beating analyst estimates, which likely contributed to the bullish market movement.
• Despite concerns about profit margin impact from tariffs, the company's solid financial performance and optimistic outlook buoyed investor confidence.
• Analysts remain bullish on ISRG, providing support for the stock even amidst technical bearish trends.
• The anticipation of strong performance in the Instruments & Accessories segment further fueled optimism among investors, driving the stock's upward trajectory.

09.05.2025 - ISRG Stock was up 2.5%

• ISRG's shares have been on a recovery path, gaining 12.7% quarter-to-date after a significant decline from its all-time high. Investors are now eyeing the stock for a potential buying opportunity.
• The company's latest innovation, the da Vinci 5 surgical system, is garnering attention for its precision, power, and potential, with strong placements in Q1 driving adoption rates.
• ISRG outpaced the stock market gains, closing the day with a 1.11% increase, showcasing resilience and investor confidence in the company's future prospects.
• The options market sentiment towards ISRG is notably bullish, indicating a positive outlook from deep-pocketed investors. This optimism could be contributing to the stock's upward momentum as market players take note of this significant move.

09.03.2025 - ISRG Stock was down 5.0%

• The decline in ISRG stock today may be linked to investors cashing in on profits following a recent upward movement.
• Optimistic activity in the options market could suggest a favorable future outlook for ISRG, notwithstanding the current short-term stock decline.
• Expectations of a positive earnings performance in the upcoming quarterly results might be fueling the overall positive sentiment, even with today's slight stock drop.

10.11.2025 - ISRG Stock was down 2.8%

• An institutional investor increased its stake in ISRG by 1.2% in Q2, despite recent insider selling by executives, following the company's strong Q3 earnings.
• Another institutional investor, Daiwa Securities Group Inc., sold 6,055 shares of ISRG, reducing its holdings, while other institutional investors also adjusted their positions in the company.
• The market movement could be attributed to profit-taking by institutional investors after a period of significant growth, despite positive earnings and analyst consensus ratings.
• The bearish trend might also be influenced by overall market conditions and investor sentiment towards the healthcare sector, as highlighted by the positive performance of other surgical equipment companies in Q3.

06.00.2026 - ISRG Stock was up 3.7%

• Despite significant insider selling and reduced stakes by asset management firms, major institutional investors increasing their positions in ISRG have likely instilled confidence in the market.
• The utilization of AI in driving growth and innovation within the medical sector has positioned companies like Intuitive Surgical for strong performance, attracting investors and contributing to the bullish movement.
• While the stock may be trading at a premium valuation with a high P/E ratio, the perceived undervaluation and potential for future growth due to product innovation and AI integration have likely fueled investor optimism, leading to the bullish market movement.

06.00.2026 - ISRG Stock was up 5.0%

• Noteworthy insider selling by Greenleaf Trust and Hennion & Walsh Asset Management Inc. did not deter overall market optimism towards ISRG today.
• Discussions around the utilization of Artificial Intelligence (AI) in the medical sector, including within companies like ISRG, likely influenced investor sentiment positively, reflecting interest in the company's growth prospects.
• ISRG's strong earnings report, surpassing revenue and EPS projections, is seen as a key factor reinforcing investor trust in the company's future performance.
• Variations in institutional investors' behavior, with some increasing stakes and others decreasing positions in ISRG, suggest diverse views on the company's long-term outlook. Nevertheless, the prevailing market sentiment remained favorable, supporting the bullish trend in ISRG.

14.00.2026 - ISRG Stock was down 5.5%

• Despite strong Q4 revenue and procedure growth, ISRG's stock saw a 6% decline in pre-market trading.
• Concerns regarding a slowdown in Ion endoluminal system placements, despite an increase in da Vinci system placements, appear to have fueled the bearish movement.
• Investor sentiment may have been influenced by the company's anticipation of a potential deceleration in da Vinci procedures growth for 2026.
• Watching for the stock's current undervaluation in comparison to estimated fair value, as well as expected advancements in AI-enabled surgery, could be crucial for potential future market movements.

02.00.2026 - ISRG Stock was down 1.2%

• The downturn in ISRG stock today may be linked to investors seizing profits following a recent rise in the stock price.
• Despite notable developments like a robust Q3 performance and increased interest from institutional investors, market sentiment could be swayed by overall uncertainty and volatility in the healthcare domain.
• The forthcoming Q4 earnings call set for January 22 might influence the stock's trajectory, as investors await insights on future growth prospects.
• The market's perception of ISRG could also be influenced by broader economic conditions and industry trends impacting healthcare and technology sectors.

22.09.2025 - ISRG Stock was up 16.5%

• ISRG exceeded Q3 earnings and revenue expectations, demonstrating robust financial performance.
• The introduction of the new da Vinci 5 system is stimulating hospital upgrades and premium pricing, potentially influencing the strong performance in Q3.
• Investors responded favorably to ISRG's solid Q3 results, resulting in a notable increase in the stock price.
• The company's consistent track record of impressive earnings and positive future prospects are likely driving the current bullish trend in ISRG's stock.

22.09.2025 - ISRG Stock was up 13.4%

• Third-quarter results revealed that Intuitive Surgical achieved $2.51 billion in revenue, a 23% increase from the previous year, surpassing predictions. The surge in da Vinci placements and global procedure growth fueled this remarkable performance.
• Despite a slight gross margin dip, the company's adjusted earnings of $2.40 per share exceeded forecasts, propelling ISRG stock by 17%.
• Investor optimism was evident as the market responded favorably to the earnings and revenue beat, showcasing confidence in Intuitive Surgical's financial prowess and industry prominence.
• With a track record of surpassing earnings estimates and a bright outlook, Intuitive Surgical is positioned to potentially surpass expectations in the future, contributing to the bullish trend in its stock value.

01.09.2025 - ISRG Stock was down 2.1%

• The bearish movement in ISRG stock may be linked to profit-taking by investors following a recent positive trend.
• Concerns over the national security review affecting the medical supply chain may have contributed to uncertainty in the healthcare sector, prompting a sell-off in ISRG shares.
• There might be worries among investors about potential disruptions in the supply chain of medical devices, including robotic surgery systems, which could impact ISRG's operations and revenue.
• The market's response to the national security review may have sparked a broader sell-off in healthcare stocks, including ISRG, as investors reevaluate the risks associated with the sector.

23.06.2025 - ISRG Stock was down 2.8%

• Despite exceeding Q2 earnings and revenue estimates, ISRG's stock took a bearish turn.
• Concerns rose among investors due to a decrease in gross margin outlook impacted by tariffs, overshadowing the positive earnings results.
• The FDA's approval for ISRG's Vessel Sealer Curved, adding to the da Vinci system's capabilities, may have been overshadowed by the margin outlook news.
• Comparisons with rival Stryker in the robotic surgery sector potentially affected investor sentiment, contributing to the bearish trend in ISRG's stock.